Skip to main content

Ritter Pharmaceuticals starts second phase of lactose intolerance trials

Ritter Pharmaceuticals has announced the dosing of the first patient in its Phase 2b/3 clinical trial of RP-G28 for the treatment of lactose intolerance.



from NutraIngredients RSS http://ift.tt/1Skc0o5
via IFTTT

Popular posts from this blog

Photo

from Bodybuilding Motivation http://ift.tt/2EtKRn5 via IFTTT